Kura Oncology (KURA) Other Operating Expenses (2010 - 2026)

Kura Oncology (KURA) reported Other Operating Expenses of $262000.0 for Q1 2026, down 98.42% on a QoQ basis from $16.6 million in Q4 2018.

Kura Oncology (KURA) has 9 years of Other Operating Expenses data on file, last reported at $262000.0 in Q1 2026.

  • Quarterly Other Operating Expenses changed N/A year-over-year to $262000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $262000.0 (changed N/A YoY) and the FY2025 annual result came in at $57000.0, changed N/A from the prior year.
  • Other Operating Expenses slipped to $262000.0 in Q1 2026 per KURA's latest filing, from $16.6 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $262000.0 in Q1 2026 and bottomed at $262000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Kura Oncology 801.92 Mn 801.92 Mn 18.00 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 262,000.00
Dec 31, 2018 16.63 Mn
Sep 30, 2018 15.98 Mn
Jun 30, 2018 15.28 Mn
Mar 31, 2018 14.99 Mn
Dec 31, 2017 11.00 Mn
Sep 30, 2017 9.50 Mn
Jun 30, 2017 7.93 Mn
Mar 31, 2017 7.65 Mn
Dec 31, 2016 7.48 Mn
Sep 30, 2016 7.06 Mn
Jun 30, 2016 5.79 Mn
Mar 31, 2016 5.84 Mn
Dec 31, 2015 12.33 Mn
Sep 30, 2015 1.01 Mn
Jun 30, 2015 3.32 Mn
Mar 31, 2015 2.55 Mn
Dec 31, 2014 3.79 Mn
Dec 31, 2012 -8,376.00
Sep 30, 2012 -4,728.00
Jun 30, 2012 -4,996.00
Mar 31, 2012 -4,241.00
Dec 31, 2011 -7,976.00
Sep 30, 2011 -5,360.00
Jun 30, 2011 -5,837.00
Mar 31, 2011 -4,266.00
Dec 31, 2010 -7,214.00
Sep 30, 2010 -4,238.00